Revenue12 Apr 2022 08:52
As the NASA engineer in the Apollo 13 film said when trying to get the crew returned safely, "power is everything"
In this case for me it's revenue that's everything. And better still repeating and growing revenue. I was viewing the Samsung case as a [very] 'nice to have', something that could validate the company, have a licence agreement and the potential of a special dividend to share holders. The prospect of the STM revenue was in many way more important to me, especially when you add in the Asian Chemical company potential and all the routes to market that opens up and that more of these customers are progressing towards orders and more will hopefully appear.....'build it and they will come!'
But in the RNS is this statement re display :
"Display materials (CFQD® Quantum Dots)
The current market for displays using quantum dots remains dominated by Samsung who have an estimated 90% share. The 10% held by other market participants which includes cadmium based systems is likely to grow in the short term and should see a move to cadmium free quantum dots as more countries limit the use of cadmium. Nanoco believe that anyone wishing to manufacture cadmium free quantum dots at scale will require a licence to our IP. The demand for material or licences from Nanoco is therefore closely linked to the outcome of the litigation against Samsung.
We continue to pursue small scale development projects with a number of customers in display opportunities and also in adjacent markets such as horticultural applications where cadmium free quantum dots lack of toxicity provides a clear commercial advantage.
We retain our core capabilities to deliver R&D services, scale up and commercial production of cadmium free quantum dots' from our Runcorn facility. We are therefore well positioned to take advantage of any broadening in the adoption of non-toxic quantum dots."
This is highly significant. Winning the Samsung case could disrupt the display market significantly and be a double edged sword for Samsung on one hand, and a double whammy for Nanoco on the other.